Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

USANA Health Sciences, Inc. USNA

Consumer Defensive  —  Packaged Foods
14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 35.69 16.31 16.50 15.17 17.72 13.16 17.77 23.04 29.74 16.13
P/S ratio 0.39 0.80 1.14 1.05 1.72 1.44 1.68 2.39 1.74 1.50
P/FCF ratio 29.27 13.45 18.66 11.21 18.79 11.22 16.14 20.12 16.50 14.44
P/Operating CF (107.33) 118.51 40.28 25.91 81.81 34.04 31.91 70.20 33.10 27.28
P/B ratio 0.68 1.29 2.11 2.41 5.16 3.69 5.06 7.26 5.02 4.62
Price to Tangible BV 1.39 2.90 2.33 2.73 5.88 4.15 5.83 8.29 5.87 5.49
EV/Sales 0.23 0.60 0.79 0.77 1.52 1.17 1.47 2.21 1.57 1.39
EV/EBITDA 2.75 5.77 6.39 5.95 9.40 6.69 9.23 12.80 11.06 9.17
EV/Operating CF 9.50 8.37 10.26 7.38 14.92 8.30 12.32 17.26 13.28 10.19
EV/FCF 17.08 10.02 12.90 8.20 16.68 9.17 14.17 18.62 14.87 13.38
Quick Ratio 1.23 1.30 2.78 2.01 1.49 1.86 1.73 1.87 1.75 1.27
Current Ratio 2.24 2.00 3.52 2.67 2.27 2.53 2.42 2.64 2.41 2.01
Net Debt/EBITDA (2.05) (2.05) (2.91) (2.24) (1.25) (1.57) (1.39) (1.35) (1.66) (1.16)
Debt/Assets 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover 1.24 1.24 1.50 1.70 1.95 1.96 1.98 2.22 2.12 2.25
Operating CF/Net income 2.08 1.45 1.11 1.50 1.04 1.29 1.26 1.21 1.98 1.37
Capex/Depreciation (0.25) (0.45) (0.71) (0.49) (0.57) (0.67) (0.72) (0.66) (0.82) (2.42)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 2.02% 8.17% 13.69% 16.72% 27.85% 31.43% 27.06% 33.47% 18.17% 33.01%
ROA 1.44% 6.09% 10.38% 11.81% 19.12% 21.53% 18.77% 23.51% 12.63% 22.38%
ROIC 6.24% 11.83% 34.88% 46.05% 68.50% 85.03% 78.17% 103.92% 71.34% 57.95%
Return on Tangible Assets 4.23% 17.95% 16.00% 20.50% 38.06% 34.86% 34.85% 37.60% 20.72% 41.57%
Average Days of Receivables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 73.49% 73.37% 70.71% 69.81% 67.29% 66.02% 68.55% 67.28% 70.22% 68.31%
Intangible Assets out of Total Assets 0.36 0.40 0.07 0.08 0.08 0.08 0.09 0.09 0.10 0.11
Share Based Compensation of Revenue 1.49% 1.70% 1.58% 1.33% 1.21% 1.27% 1.46% 1.26% 1.48% 1.64%
Graham Net Nets 0.22 0.09 0.27 0.21 0.09 0.14 0.09 0.08 0.10 0.09
Graham Number 18.87 37.13 43.79 42.69 50.20 52.46 39.30 43.19 29.08 34.16
Earnings Yield 2.80% 6.13% 6.06% 6.59% 5.64% 7.60% 5.63% 4.34% 3.36% 6.20%
Free Cash Flow Yield 3.42% 7.44% 5.36% 8.92% 5.32% 8.91% 6.19% 4.97% 6.06% 6.93%
Revenue per Share 49.92 44.73 47.84 51.86 58.89 53.63 46.85 49.34 43.01 41.60
Operating CF per Share 1.21 3.19 3.67 5.40 6.02 7.58 5.60 6.31 5.08 5.66
Capex per Share (0.54) (0.52) (0.75) (0.54) (0.63) (0.71) (0.73) (0.46) (0.54) (1.35)
Free Cash Flow per Share 0.67 2.67 2.92 4.86 5.38 6.87 4.87 5.85 4.54 4.31
Cash per Share 8.54 9.52 17.16 14.98 11.90 14.74 10.37 11.53 10.15 7.27
Shareholders Equity per Share 28.76 27.85 25.83 22.57 19.61 20.88 15.53 16.23 14.92 13.45
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 28.76 27.85 25.83 22.57 19.61 20.88 15.53 16.23 14.92 13.45
Free Cash Flow 12.43 50.98 56.16 93.51 108.48 145.31 110.18 141.07 110.58 104.20
Working Capital 159.84 139.56 298.90 240.55 204.33 257.21 193.18 243.65 198.98 139.37
Capital Expenditures (9.92) (10.01) (14.48) (10.39) (12.75) (15.09) (16.55) (11.05) (13.20) (32.69)
Net Current Asset Value 78.59 63.10 282.19 222.31 182.50 226.05 164.06 229.02 184.10 132.51
EV/EBIT 5.67 7.70 7.79 7.13 10.63 7.55 10.68 13.94 12.41 10.06
Capex to Sales 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.03
Net Profit Margin 1.16% 4.92% 6.93% 6.94% 9.82% 10.99% 9.48% 10.61% 5.97% 9.94%
Price to Operating Income 9.72 10.34 11.26 9.74 11.98 9.24 12.17 15.07 13.77 10.85
Other line items
Depreciation/Fixed assets 0.42 0.24 0.20 0.22 0.22 0.22 0.24 0.18 0.16 0.13
Cash ROIC (10.42%) (4.70%) (3.52%) 0.85% 3.06% 7.96% 5.37% 8.98% 3.43% 7.11%
Accounts Receivable Turnover 0.00 0.00 0.00 138.93 162.72 140.24 93.09 86.53 68.67 65.97
Accounts Payable Turnover 13.73 14.62 16.73 15.79 13.75 13.61 16.69 18.47 17.23 18.88
Inventory Turnover 2.33 2.46 2.75 2.34 2.31 2.63 2.49 2.77 2.81 2.75
Average Days of Payables 31.37 27.13 20.80 20.80 22.63 31.76 24.38 18.09 23.98 18.31
Days of Inventory on Hand 186.47 157.89 126.95 126.30 164.69 157.48 134.13 149.03 128.01 131.28
Average Receivables — — — 7.19 7.29 8.09 11.40 13.74 15.25 15.25
Average Payables 14.62 11.03 10.56 12.28 15.85 15.36 11.24 10.87 10.41 9.54
Average Inventory 86.17 65.59 64.27 82.70 94.27 79.56 75.43 72.43 63.86 65.46
Average Assets 745.55 690.48 614.65 587.14 609.31 578.91 535.70 536.87 494.96 446.94
Average Common Equity 532.61 514.66 465.84 414.80 418.39 396.68 371.43 377.18 344.25 303.07

Fold the line items

Columns are period end dates